Shanghai Shijian Biotechnology
At a glance
- Status
- Operational
- Open positions
- None listed
- Dealroom signal
- 11.6/100
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | May 2023 | $14M | $55M | Hetang Venture Capital · Shenzhen Investment Holding Donghai | ↗ |
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Shanghai Shijian Biotechnology in its local ecosystem
The Shanghai Shijian Biotechnology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
- SDShenzhen Investment Holding Donghai
- HCHetang Venture Capital
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Shanghai Shijian Biotechnology on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Shanghai Shijian Biotechnology’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.